Market Insights

Zydis Patient Compliance

New Data Shows Drug Delivery Has Positive Impact on Patient Compliance

Authors: Steven Hamlen, MBA, Director - Strategic Marketing, Karen MacGregor, PhD, Director - Product Development, & Editor, Drug Delivery & Development

Patient non-compliance in America is a major medical problem with an estimated cost in excess of $290 billion a year, according to a report from the New England Healthcare Institute. While researchers have identified improved patient education about disease management and medications, pharmacist and physician assistance, and simplified drug regimens as means for improving compliance, many in the pharmaceutical community are recognizing that drug delivery may also be an influential factor. A recent study of longitudinal patient records at Catalent Pharma Solutions supports the theory that drug delivery can improve patient medication compliance. The 1-year study compared the compliance rates of two oral delivery methods for delivery of selegiline: standard pill and an orally disintegrating tablet (ODT) formulation that achieved pre-gastric absorption. Results showed an increase in compliance rate with the ODT formulation compared to the standard oral treatment in US Medicare patients.